[HTML] nih.gov

[HTML][HTML] Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta …

J Yang, J Zhang, T Han, C Liu, X Li, L Yan, B Yang… - Medicine, 2020 - ncbi.nlm.nih.gov
Background: Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …
被引用次数：24 相关文章
[HTML] lww.com

[HTML][HTML] Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta …

J Yang, J Zhang, T Han, C Liu, X Li, L Yan, B Yang… - Medicine, 2020 - journals.lww.com
Background: Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …

Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis.

J Yang, J Zhang, T Han, C Liu, X Li, L Yan, B Yang… - Medicine, 2020 - europepmc.org
Background Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …

Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis

J Yang, J Zhang, T Han, C Liu, X Li, L Yan… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non …